The University of Saskatchewan Vaccine and Infectious Disease Organization (VIDO) and the Switzerland-based Vaccine Formulation Institute (VFI) have established a partnership to support a rapid and unified response to future pandemics. The partners will work together to develop and test vaccine formulations for emerging pathogens. “Preparing for future pandemics requires a co-ordinated, international effort,” explained USask VIDO Director Dr Volker Gerdts. “We are delighted to further our partnership with VFI. The technologies developed will help ensure a rapid response to the next emerging infectious disease.”
USask
